Cargando…

Clinical assessment of heartworm‐infected Beagles treated with a combination of imidacloprid/moxidectin and doxycycline, or untreated

BACKGROUND: Administration of moxidectin topically and doxycycline PO has been utilized experimentally as an alternative treatment for heartworm disease. However, clinical effects of this protocol remain poorly characterized. OBJECTIVE: To evaluate the clinical and postmortem findings associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savadelis, Molly D., Coleman, Amanda E., Rapoport, Gregg S., Sharma, Ajay, Sakamoto, Kaori, Keys, Deborah A., Ohmes, Cameon M., Hostetler, Joe A., Dzimianski, Michael T., Moorhead, Andrew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517868/ https://www.ncbi.nlm.nih.gov/pubmed/32691900 http://dx.doi.org/10.1111/jvim.15853

Ejemplares similares

Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline
por: Savadelis, Molly D., et al.
Publicado: (2017)

Evaluation of heat-treating heartworm-positive canine serum samples during treatment with Advantage Multi(®) for Dogs and doxycycline
por: Savadelis, Molly D., et al.
Publicado: (2018)

Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi(®) for Dogs) for the prevention of heartworm disease and infection all month long
por: Bowman, Dwight D., et al.
Publicado: (2017)

Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment
por: Bendas, Alexandre José Rodrigues, et al.
Publicado: (2017)

Efficacy and side effects of doxycycline versus minocycline in the three-dose melarsomine canine adulticidal heartworm treatment protocol
por: Savadelis, Molly D., et al.
Publicado: (2018)

Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance
por: Savadelis, Molly D., et al.
Publicado: (2022)

Effects of doxycycline dose rate and pre-adulticide wait period on heartworm-associated pathology and adult worm mass
por: Moorhead, Andrew R., et al.
Publicado: (2023)

Safety of Simparica Trio(®) (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
por: Mathur, Sheerin, et al.
Publicado: (2023)

Efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 Ctenocephalides felis flea strain infesting cats
por: Dryden, Michael W, et al.
Publicado: (2011)

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid
por: Huang, Hui-Pi, et al.
Publicado: (2013)

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis
por: Fourie, Josephus J., et al.
Publicado: (2019)

Intracardiac heartworms in dogs: Clinical and echocardiographic characteristics in 72 cases (2010‐2019)
por: Romano, Abigail E., et al.
Publicado: (2020)

Aberrant migration and surgical removal of a heartworm (Dirofilaria immitis) from the femoral artery of a cat
por: Oldach, Maureen S., et al.
Publicado: (2018)

Clinical Phenotype of Musladin‐Lueke Syndrome in 2 Beagles
por: Packer, R.A., et al.
Publicado: (2017)

Clinical benefits of incorporating doxycycline into a canine heartworm treatment protocol
por: Nelson, C. Thomas, et al.
Publicado: (2017)

Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease
por: Papich, Mark G.
Publicado: (2017)

First Feline Case of Otodectosis in the Republic of Korea and Successful Treatment with Imidacloprid/Moxidectin Topical Solution
por: Ahn, Ah-Jin, et al.
Publicado: (2013)

Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis
por: Heuer, Lea, et al.
Publicado: (2020)

Minimum transmission time of Cytauxzoon felis by Amblyomma americanum to domestic cats in relation to duration of infestation, and investigation of ingestion of infected ticks as a potential route of transmission
por: Thomas, Jennifer E, et al.
Publicado: (2017)

A retrospective case series of clinical signs in 28 Beagles with Lafora disease
por: Flegel, Thomas, et al.
Publicado: (2021)

Efficacy and safety of imidacloprid 10 %/moxidectin 1 % spot-on formulation in the treatment of feline infection by Capillaria aerophila
por: Traversa, Donato, et al.
Publicado: (2012)

Diagnostic features of type II fibrinoid leukodystrophy (Alexander disease) in a juvenile Beagle dog
por: Vandenberghe, Hélène, et al.
Publicado: (2023)

Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs
por: Hwang, J.‐H., et al.
Publicado: (2017)

Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease
por: Alisauskaite, Neringa, et al.
Publicado: (2020)

Effect of Therapy by Using Advocate Spot-On Combination (Imidacloprid 10% and Moxidectin 2.5%) on Subcutaneous Dirofilariosis in Dogs
por: Paran, Radmila Dobešová, et al.
Publicado: (2011)

Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
por: Otranto, Domenico, et al.
Publicado: (2019)

Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
por: McTier, Tom L., et al.
Publicado: (2019)

Prospective long‐term evaluation of parenteral hydroxocobalamin supplementation in juvenile beagles with selective intestinal cobalamin malabsorption (Imerslund‐Gräsbeck syndrome)
por: Kook, Peter Hendrik, et al.
Publicado: (2018)

Inability of Dirofilaria immitis infective larvae from mosquitoes fed on blood from microfilaremic dogs during low-dose and short-treatment regimens of doxycycline and ivermectin to complete normal development in heartworm naïve dogs
por: McCall, John Wilson, et al.
Publicado: (2023)

Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris)
por: Kim, Kyu-Rim, et al.
Publicado: (2012)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Daily oral cyanocobalamin supplementation in Beagles with hereditary cobalamin malabsorption (Imerslund‐Gräsbeck syndrome) maintains normal clinical and cellular cobalamin status
por: Kook, Peter H., et al.
Publicado: (2018)

ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
por: McTier, Tom L., et al.
Publicado: (2019)

Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
por: Le Sueur, Christophe, et al.
Publicado: (2010)

Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate(®)) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece
por: Diakou, Anastasia, et al.
Publicado: (2019)

Solvatomorphism of Moxidectin
por: Grell, Toni, et al.
Publicado: (2021)

Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs
por: Ciuca, Lavinia, et al.
Publicado: (2023)

Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016)

Determining resolution of Angiostrongylus vasorum in dogs following anthelmintic treatment with an imidacloprid 10 per cent/moxidectin 2.5 per cent spot-on
por: Bird, Louise Elizabeth, et al.
Publicado: (2018)

Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats
por: Traversa, Donato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7t86jb96u3sfp3a3hcq5iia2ii